344 related articles for article (PubMed ID: 34177178)
1. Drug-related Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review.
Arora R; Pande RK; Panwar S; Gupta V
Indian J Crit Care Med; 2021 May; 25(5):575-579. PubMed ID: 34177178
[TBL] [Abstract][Full Text] [Related]
2. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
[TBL] [Abstract][Full Text] [Related]
3. A Compilation of Drug Etiologies of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Abulatan IT; Ben-David SG; Morales-Colon LA; Beason E; Fakoya AO
Cureus; 2023 Nov; 15(11):e48728. PubMed ID: 38094551
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study.
Chow LLW; Shih KC; Chan JCY; Lai JSM; Ng ALK
BMC Ophthalmol; 2017 May; 17(1):65. PubMed ID: 28499410
[TBL] [Abstract][Full Text] [Related]
5. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
[TBL] [Abstract][Full Text] [Related]
6. Analysis of clinical features of oxcarbazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.
Yan Q; Liu X; Lei H; Liu R; Hu Y
Front Med (Lausanne); 2023; 10():1232969. PubMed ID: 37881633
[TBL] [Abstract][Full Text] [Related]
7. Role of nanocrystalline silver dressings in the management of toxic epidermal necrolysis (TEN) and TEN/Stevens-Johnson syndrome overlap.
Smith SD; Dodds A; Dixit S; Cooper A
Australas J Dermatol; 2015 Nov; 56(4):298-302. PubMed ID: 25368980
[TBL] [Abstract][Full Text] [Related]
8. Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed/MEDLINE case reports from 1980 to 2020.
Wang L; Varghese S; Bassir F; Lo YC; Ortega CA; Shah S; Blumenthal KG; Phillips EJ; Zhou L
Front Med (Lausanne); 2022; 9():949520. PubMed ID: 36091694
[TBL] [Abstract][Full Text] [Related]
9. Stevens-Johnson syndrome and toxic epidermal necrolysis.
Harr T; French LE
Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
[TBL] [Abstract][Full Text] [Related]
10. Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center.
Gleghorn KL; Voigt C; Kelly B
Pediatr Dermatol; 2021 Jul; 38(4):812-818. PubMed ID: 34060145
[TBL] [Abstract][Full Text] [Related]
11. Carbamazepine-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Treated Successfully with Oral Cyclosporin: Case report and literature review.
Al Rajaibi R; Al Rumhi T; Al Abri AM
Sultan Qaboos Univ Med J; 2021 Aug; 21(3):491-494. PubMed ID: 34522420
[TBL] [Abstract][Full Text] [Related]
12. [Drug-induced toxic epidermal necrolysis with secondary aspergillus fumigatus infection: a case report].
Zhang S; Liu XY; Zhang JZ; Cai L; Zhou C
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Oct; 51(5):977-980. PubMed ID: 31624410
[TBL] [Abstract][Full Text] [Related]
13. Stevens-Johnson syndrome-toxic epidermal necrolysis (SJS-TEN) overlap associated with carbamazepine use.
Suresh Kumar PN; Thomas B; Kumar K; Kumar S
Indian J Psychiatry; 2005 Apr; 47(2):121-3. PubMed ID: 20711297
[TBL] [Abstract][Full Text] [Related]
14. Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications.
Ueta M
Expert Rev Clin Immunol; 2020 Mar; 16(3):285-291. PubMed ID: 32045311
[No Abstract] [Full Text] [Related]
15. Disease severity and status in Stevens-Johnson syndrome and toxic epidermal necrolysis: Key knowledge gaps and research needs.
Lehloenya RJ
Front Med (Lausanne); 2022; 9():901401. PubMed ID: 36172538
[TBL] [Abstract][Full Text] [Related]
16. [Ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis].
Chronopoulos A; Mockenhaupt M; Pleyer U
Ophthalmologe; 2021 May; 118(5):519-532. PubMed ID: 33725172
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and treatment outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Chantaphakul H; Sanon T; Klaewsongkram J
Exp Ther Med; 2015 Aug; 10(2):519-524. PubMed ID: 26622347
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the patients diagnosed with Stevens Johnson syndrome and toxic epidermal necrolysis: a single center experience.
Çekiç Ş; Canıtez Y; Sapan N
Turk Pediatri Ars; 2016 Sep; 51(3):152-158. PubMed ID: 27738400
[TBL] [Abstract][Full Text] [Related]
19. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management.
Sane SP; Bhatt AD
J Assoc Physicians India; 2000 Oct; 48(10):999-1003. PubMed ID: 11200928
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
